Virbac Milpro Puppy 2.5mg/25mg

Virbac Milpro Puppy 2.5mg (0.5-10kg) per Tablet Milpro Puppies contains 2,5 mg milbemycin oxime and 25 mg praziquantel per tablet. A small and very palatable tablet that is a broad spectrum deworming tablet. INDICATIONS: Milpro is a broad spectrum film coated tablet for dogs, which treats and controls larval and adult stages of hookworms (Ancylostoma caninum), roundworms (Toxocara canis, Toxascaris leonina) and whipworms (Trichuris vulpis). Milpro also treats and controls all stages of tapeworm infections (Dipylidium caninum, Taenia spp., Echinococcus spp.,Mesocestoides spp.) and Sprirocerca lupi. DIRECTIONS FOR USE: Use only as directed. Only for use by persons authorised thereto in terms the Veterinary and Para-Veterinary Professions Act, 1982 (Act 19 of 1982) In dogs: The minimum recommended dose rate is 0,5 mg milbemycin oxime and 5 mg praziquantel per kg body mass, administered as a single oral dose. Milpro should be administered with or after food for maximum efficacy. Adult dogs should be treated 4 times a year. Depending on the body mass of the dog, practical dosing is as follows: Body mass dog Milpro Puppies 0,5 – 1 kg ½ Tablet 1 – 5 kg 1 Tablet 5 – 10 kg 2 Tablets 10 – 15 kg 3 Tablets 15 – 20 kg 4 Tablets 20 – 25 kg 5 Tablets EFFICACY: Milpro has been shown to be highly effective in treating mixed infections of cestodes and nematodes of the following species: Cestodes: Dipylidium caninum, Taenia spp., Echinococcus spp., Mesocestoides spp. Nematodes: Ancylostoma caninum, Toxocara canis, Toxascaris leonina, Trichuris vulpis, Sprirocerca lupi. WARNINGS: Do not use in pregnant or nursing bitches. Do not use in puppies younger than 6 weeks of age. Do not use Milpro Dogs in dogs with a body mass of less than 5 kg. The margin of safety of Milpro in Collies or related dog breeds is less than in other breeds. As such, the recommended dose should be strictly observed in these breeds. Echinococcus spp. represents a hazard for humans (zoonosis). If Echinococcus spp. has been detected, specific treatment and follow-up guidelines should be followed, whilst steps should be taken to safe-guard persons. No studies have been performed in severely debilitated dogs or individuals with seriously compromised kidney or liver function. Milpro is not recommended for such animals and should only be used, following a risk/benefit assessment by the responsible veterinarian. At 10 times and higher dose rates (overdosing), mild transient clinical signs of mydriasis, depression, drooling, paresis, trembling and/or a staggered gait may occur in some dogs. Such symptoms will subside spontaneously within a day. No antidote is known. Keep out of reach of children, uninformed persons and animals. Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder. PRECAUTIONS: The concurrent use of Milpro with